US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 11.100
  • -0.150-1.33%
Close Feb 25 16:00 ET
  • 11.100
  • 0.0000.00%
Post 16:32 ET
766.41MMarket Cap-3.83P/E (TTM)

Bicycle Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
30.76%35.28M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
86.52%26.98M
67.38%5.33M
76.05%5.35M
160.32%11.4M
26.84%4.9M
Operating revenue
30.76%35.28M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
86.52%26.98M
67.38%5.33M
76.05%5.35M
160.32%11.4M
26.84%4.9M
Cost of revenue
Gross profit
Operating expense
12.99%244.43M
18.49%70.8M
19.42%66.2M
2.21%56.11M
10.97%51.32M
64.99%216.33M
66.02%59.75M
67.99%55.44M
77.10%54.9M
48.56%46.25M
Selling and administrative expenses
19.44%71.46M
39.66%21.02M
15.23%17.94M
5.75%16.05M
17.23%16.45M
20.86%59.83M
33.56%15.05M
51.92%15.57M
36.20%15.18M
-16.69%14.04M
-General and administrative expense
19.44%71.46M
39.66%21.02M
15.23%17.94M
5.75%16.05M
17.23%16.45M
20.86%59.83M
33.56%15.05M
51.92%15.57M
36.20%15.18M
-16.69%14.04M
Research and development costs
10.52%172.97M
11.37%49.78M
21.06%48.27M
0.85%40.06M
8.24%34.86M
91.76%156.5M
80.82%44.7M
75.23%39.87M
100.06%39.72M
125.50%32.21M
Operating profit
-10.46%-209.15M
-23.29%-67.09M
-26.84%-63.53M
-7.46%-46.75M
23.13%-31.79M
-62.32%-189.35M
-65.89%-54.42M
-67.17%-50.08M
-63.41%-43.5M
-51.63%-41.35M
Net non-operating interest income expense
203.14%32.55M
87.88%10.25M
232.70%10.55M
77,322.22%6.95M
126.45%4.8M
345.23%10.74M
200.94%5.46M
170.10%3.17M
-136.00%-9K
453.50%2.12M
Non-operating interest income
144.85%34.28M
64.17%10.3M
165.57%10.58M
857.39%7.77M
92.01%5.62M
143.26%14M
137.82%6.28M
100.15%3.99M
-10.57%812K
1,243.58%2.93M
Non-operating interest expense
-46.98%1.73M
-93.66%52K
-95.95%33K
0.37%824K
1.61%821K
-2.42%3.26M
-0.73%820K
-0.37%814K
-7.02%821K
-1.22%808K
Other net income (expense)
571.89%2.8M
2,033.33%3.9M
-78.29%-1.27M
-74.10%101K
115.67%71K
-594K
183K
-457.00%-714K
157.35%390K
-300.88%-453K
Gain on sale of security
-21.04%-719K
-412.57%-572K
55.32%-319K
-74.10%101K
115.67%71K
---594K
--183K
-457.00%-714K
157.35%390K
-300.88%-453K
Special income (charges)
---954K
--0
---954K
----
----
--0
--0
--0
----
----
-Less:Other special charges
--954K
--0
--954K
----
----
----
----
----
----
----
Other non- operating income (expenses)
--4.48M
----
----
----
----
----
----
----
----
----
Income before tax
3.02%-173.8M
-8.52%-52.94M
-13.91%-54.25M
7.94%-39.7M
32.18%-26.91M
-56.87%-179.21M
-60.47%-48.78M
-66.61%-47.63M
-58.09%-43.12M
-41.81%-39.68M
Income tax
-427.04%-4.77M
-438.13%-1.08M
-251.76%-3.45M
122.24%115K
43.37%-350K
195.60%1.46M
176.19%320K
1,054.62%2.27M
-15.66%-517K
-47.49%-618K
Net income
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
Net income continuous Operations
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
Minority interest income
Net income attributable to the parent company
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
Basic earnings per share
42.91%-2.9
35.34%-0.75
41.27%-0.74
45.39%-0.77
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.3
Diluted earnings per share
42.91%-2.9
35.34%-0.75
41.27%-0.74
45.39%-0.77
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 30.76%35.28M-30.44%3.71M-50.00%2.68M-17.86%9.36M298.90%19.53M86.52%26.98M67.38%5.33M76.05%5.35M160.32%11.4M26.84%4.9M
Operating revenue 30.76%35.28M-30.44%3.71M-50.00%2.68M-17.86%9.36M298.90%19.53M86.52%26.98M67.38%5.33M76.05%5.35M160.32%11.4M26.84%4.9M
Cost of revenue
Gross profit
Operating expense 12.99%244.43M18.49%70.8M19.42%66.2M2.21%56.11M10.97%51.32M64.99%216.33M66.02%59.75M67.99%55.44M77.10%54.9M48.56%46.25M
Selling and administrative expenses 19.44%71.46M39.66%21.02M15.23%17.94M5.75%16.05M17.23%16.45M20.86%59.83M33.56%15.05M51.92%15.57M36.20%15.18M-16.69%14.04M
-General and administrative expense 19.44%71.46M39.66%21.02M15.23%17.94M5.75%16.05M17.23%16.45M20.86%59.83M33.56%15.05M51.92%15.57M36.20%15.18M-16.69%14.04M
Research and development costs 10.52%172.97M11.37%49.78M21.06%48.27M0.85%40.06M8.24%34.86M91.76%156.5M80.82%44.7M75.23%39.87M100.06%39.72M125.50%32.21M
Operating profit -10.46%-209.15M-23.29%-67.09M-26.84%-63.53M-7.46%-46.75M23.13%-31.79M-62.32%-189.35M-65.89%-54.42M-67.17%-50.08M-63.41%-43.5M-51.63%-41.35M
Net non-operating interest income expense 203.14%32.55M87.88%10.25M232.70%10.55M77,322.22%6.95M126.45%4.8M345.23%10.74M200.94%5.46M170.10%3.17M-136.00%-9K453.50%2.12M
Non-operating interest income 144.85%34.28M64.17%10.3M165.57%10.58M857.39%7.77M92.01%5.62M143.26%14M137.82%6.28M100.15%3.99M-10.57%812K1,243.58%2.93M
Non-operating interest expense -46.98%1.73M-93.66%52K-95.95%33K0.37%824K1.61%821K-2.42%3.26M-0.73%820K-0.37%814K-7.02%821K-1.22%808K
Other net income (expense) 571.89%2.8M2,033.33%3.9M-78.29%-1.27M-74.10%101K115.67%71K-594K183K-457.00%-714K157.35%390K-300.88%-453K
Gain on sale of security -21.04%-719K-412.57%-572K55.32%-319K-74.10%101K115.67%71K---594K--183K-457.00%-714K157.35%390K-300.88%-453K
Special income (charges) ---954K--0---954K----------0--0--0--------
-Less:Other special charges --954K--0--954K----------------------------
Other non- operating income (expenses) --4.48M------------------------------------
Income before tax 3.02%-173.8M-8.52%-52.94M-13.91%-54.25M7.94%-39.7M32.18%-26.91M-56.87%-179.21M-60.47%-48.78M-66.61%-47.63M-58.09%-43.12M-41.81%-39.68M
Income tax -427.04%-4.77M-438.13%-1.08M-251.76%-3.45M122.24%115K43.37%-350K195.60%1.46M176.19%320K1,054.62%2.27M-15.66%-517K-47.49%-618K
Net income 6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M
Net income continuous Operations 6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M
Minority interest income
Net income attributable to the parent company 6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M
Basic earnings per share 42.91%-2.935.34%-0.7541.27%-0.7445.39%-0.7752.31%-0.62-33.68%-5.08-14.85%-1.16-31.25%-1.26-56.67%-1.41-39.78%-1.3
Diluted earnings per share 42.91%-2.935.34%-0.7541.27%-0.7445.39%-0.7752.31%-0.62-33.68%-5.08-14.85%-1.16-31.25%-1.26-56.67%-1.41-39.78%-1.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Taylor Morrison Home
TMHC
+5.50%
Meritage Homes
MTH
+5.08%
D.R. Horton
DHI
+4.50%
Lennar Corp
LEN
+3.76%
Toll Brothers
TOL
+3.66%

Unlock the Full List